Health Exchange
@MWHealthBlog
The most important news, data and analysis on the $3 trillion health care industry from @RussBrittMKTW and @MarketWatch.
You might like
As election hits, politics collides with Ebola -- marketwatch.com/story/in-time-…
marketwatch.com
In time for election, politics collides with Ebola
Just in time for next week’s elections, political leaders are injecting themselves into the issue.
Hospitals scramble to get up to speed on Ebola -- marketwatch.com/story/hospital…
marketwatch.com
Hospitals scramble to get up to speed on Ebola
Hospitals like Bellevue Hospital in New York are scrambling to get up to speed on Ebola to treat people like Dr. Craig Spencer, who tested positive for the deadly virus upon his recent return to New...
Ebola nation travelers to be watched 21 days -- marketwatch.com/story/ebola-na…
marketwatch.com
Ebola-nation travelers to U.S. to be watched 21 days
Amid calls for a travel ban from West Africa, U.S. health officials say they will monitor those traveling from Ebola-stricken nations for three weeks
Gilead's new drug pricier than $1,000-a-day Sovaldi -- marketwatch.com/story/gileads-…
marketwatch.com
Gilead’s new drug is even pricier than Sovaldi
Gilead’s new hepatitis C drug is even pricier than its $1,000-a-day Sovaldi.
You can easily get to Dallas, where Ebola patient died, without going through planned screening -- marketwatch.com/story/the-hole…
marketwatch.com
Many flights from Ebola-hit countries bypass special screening
A check of airlines schedules shows that even if health officials are able to check the 94% of West African passengers they claim, a significant number of flights will bypass the extra security.
The holes in the U.S. Ebola screening strategy -- marketwatch.com/story/the-hole…
marketwatch.com
Many flights from Ebola-hit countries bypass special screening
A check of airlines schedules shows that even if health officials are able to check the 94% of West African passengers they claim, a significant number of flights will bypass the extra security.
Ebola drug developers see stocks jump on reported virus case in U.S. blogs.marketwatch.com/thetell/2014/0…
First U.S. Ebola case is confirmed -- marketwatch.com/story/us-finds…
marketwatch.com
U.S. finds first Ebola case, CDC confirms
An adult who recently traveled from West Africa to Texas has tested positive for Ebola, the first case to be diagnosed in the U.S., health officials say.
J&J's Alios purchase will help it compete with Gilead on several fronts -- blogs.marketwatch.com/health-exchang…
Big shareholders throw cold water on Allergan plans for a takeover defense -- blogs.marketwatch.com/health-exchang… blogs.marketwatch.com/health-exchang…
Private exchanges gain popularity, while Obamacare lags behind -- blogs.marketwatch.com/health-exchang…
Valeant gets vote of confidence from a board member -- blogs.marketwatch.com/health-exchang…
HHS says Obamacare will bring down hospitals' bad debt by $5.7 billion -- blogs.marketwatch.com/health-exchang…
Shire's deal with feds on drug claims is only a fraction of sales on those drugs -- blogs.marketwatch.com/health-exchang…
Scorecards needed for Allergan-Valeant soap opera -- blogs.marketwatch.com/health-exchang…
United States Trends
- 1. Seahawks N/A
- 2. Sam Darnold N/A
- 3. Rams N/A
- 4. Stafford N/A
- 5. Vikings N/A
- 6. Pats N/A
- 7. McVay N/A
- 8. Puka N/A
- 9. #RHOP N/A
- 10. gerard N/A
- 11. Woolen N/A
- 12. #BaddiesUSA N/A
- 13. #AKnightOfTheSevenKingdoms N/A
- 14. Kupp N/A
- 15. #IndustryHBO N/A
- 16. Stacey N/A
- 17. #mcrperu N/A
- 18. Romeo N/A
- 19. Mike Macdonald N/A
- 20. Signal N/A
Something went wrong.
Something went wrong.